The mission of the Pharmacotherapy Division is to educate and train the future leaders of pharmacy, engage in innovative research, and provide exemplary patient care. Our vision is to be a leader in practice-related education, clinical and translational research, and professional service.
The Division of Pharmacotherapy is one of five divisions within the College of Pharmacy. The division is unique to other divisions beginning with its physical location 75 miles south of Austin at the Health Science Center in San Antonio.
Pharmacotherapy's mission is to educate and train the future leaders of pharmacy, engage in innovative research, and provide exemplary patient care. The division is the home base for many students engaged in either a one- or two-year specialty practice residency program or a two- or three-year clinical science fellowship.
Chris Frei, Pharm.D. serves as division head. The division consists of full- and part-time faculty as well as office personnel. Most faculty offices are found in the McDermott Clinical Sciences Building. The division is also home to the Pharmacotherapy Office of Evidence-Based and Interprofessional Education.
The Pharmacotherapy Division was established in the mid-1970s as the home of the college's post B.S. Pharm.D. program. After being a presence in San Antonio for almost 25 years, the division settled into its permanent home in 1991 on the third floor of the new McDermott Clinical Sciences Building. Within the Health Science Center, the faculty and staff moved from being a part of the Department of Pharmacology to the Pharmacotherapy Education and Research Center in the School of Medicine in 2006. Although the division finds its physical home in San Antonio within the School of Medicine, staff and faculty primarily are employees of The University of Texas at Austin College of Pharmacy.
Education & Research Ctr.
College of Pharmacy
The University of Texas
Health Science Center
7703 Floyd Curl Drive - MC 6220
San Antonio, TX
Email Address: pharmacy
Dr. Kelly Reveles, assistant professor of pharmacotherapy, is primary author of a study which found that the incidence of Clostridium difficile infection (CDI), a highly contagious gastrointestinal disease often linked to the overprescribing of antibiotics, nearly doubled between 2001 and 2010. It also determined there were no improvements in patient health outcomes, including mortality or hospital length of stay, over the study period.